Fluetizolam

Fluetizolam is classified as a novel benzodiazepine. Benzodiazepines are central nervous system depressants. Novel benzodiazepines, typically defined as emergent benzodiazepines not used medicinally, are often pirated from early drug discovery or pharmaceutical studies. Novel benzodiazepines have appeared on illicit drug markets in recent years and have caused adverse events, as described in the literature; fatalities linked to novel benzodiazepine use have occurred, commonly when used in combination with other depressants (e.g., opioids and alcohol). Fluetizolam is structurally similar to etizolam and other novel benzodiazepines. Fluetizolam is not federally controlled in the United States.

Class:

Benzodiazepine

Appearance:

Plasma

Formula:

C17H15FN4S

MW:

326.4

[M+]:

326

[M+H]+:

327.1074

IUPAC:

4-ethyl-7-(2-fluorophenyl)-13-methyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaene

Report Date:

December 8, 2022